Arterial regeneration and clinical improvement of secondary autoimmune Raynaud's syndrome with autologous bone marrow mononuclear cells (aBM-MNC). early results of phase II clinical trial

Cytotherapy ◽  
2017 ◽  
Vol 19 (5) ◽  
pp. e4
Author(s):  
Jhann Arturo ◽  
Carlos Perez ◽  
Angie L. Vivas Sandoval ◽  
Carlos Ruiz ◽  
Octavio Segura ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bone Marrow ◽  
Clinical Improvement ◽  
Phase Ii ◽  
Mononuclear Cells ◽  
Autologous Bone Marrow ◽  
Phase Ii Clinical Trial ◽  
Bone Marrow Mononuclear Cells ◽  
Early Results ◽  
Autologous Bone

Early Results of Core Decompression and Autologous Bone Marrow Mononuclear Cells Instillation in Femoral Head Osteonecrosis

2012 ◽  
Vol 27 (5) ◽  
pp. 679-686 ◽  
Author(s):  
Ramesh Kumar Sen ◽  
Sujit Kumar Tripathy ◽  
Sameer Aggarwal ◽  
Neelam Marwaha ◽  
Ratti Ram Sharma ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Femoral Head ◽  
Mononuclear Cells ◽  
Core Decompression ◽  
Autologous Bone Marrow ◽  
Bone Marrow Mononuclear Cells ◽  
Femoral Head Osteonecrosis ◽  
Early Results ◽  
Autologous Bone

Phase I Clinical Trial of Autologous Bone Marrow Mononuclear Cells for Pediatric Severe Traumatic Brain Injury

Neurosurgery ◽  
2009 ◽  
Vol 65 (2) ◽  
pp. 412-412
Author(s):  
Charles S. Cox ◽  
James E. Baumgartner ◽  
Laura Worth ◽  
Matthew T. Harting ◽  
Linda Ewing-Cobbs ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Traumatic Brain Injury ◽  
Bone Marrow ◽  
Brain Injury ◽  
Phase I ◽  
Severe Traumatic Brain Injury ◽  
Mononuclear Cells ◽  
Autologous Bone Marrow ◽  
Bone Marrow Mononuclear Cells ◽  
Autologous Bone
Sign in / Sign up

Export Citation Format

Share Document